NCT01798550View on ClinicalTrials.gov

Enoxaparin Dosing in Obesity

PHASE4CompletedINTERVENTIONAL

Enrollment

62

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

October 1, 2016

Study Completion Date

October 15, 2016

Conditions

Obesity

Interventions

DRUG

Enoxaparin

Twice daily dosing

Trial Locations (1)

30303

Grady Memorial Hospital, Atlanta

All Listed Sponsors

lead

Emory University

OTHER

NCT01798550 - Enoxaparin Dosing in Obesity | Biotech Hunter | Biotech Hunter